REG - Oxford Nanopore Tech - Director/PDMR Shareholding - LTIP and DBP awards

Oxford Nanopore TechnologiesAnnouncement

Wed 17:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260415:nRSO6414Aa&default-theme=true

RNS Number : 6414A  Oxford Nanopore Technologies plc  15 April 2026

15 April 2026

Oxford Nanopore Technologies plc (the "Company")

Vesting of DBP awards; Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

The Company announces the following transactions in connection with certain of
its employee share plans.

Vesting of 2024 and 2025 Deferred Bonus Plan 2021 ("DBP") awards

On 11 April 2026, 50% of the DBP awards made to Nicholas Keher, a person
discharging managerial responsibilities ("PDMR"), in 2024 and 2025 vested and
the awards were satisfied through the issue of new ordinary shares of £0.0001
each ("Shares") on 14 April 2026 as follows:

 Nicholas Keher (Director)  48,920

Nicholas Keher then sold sufficient Shares to meet his tax liabilities in
respect of the vesting of his award.

 

Nicholas Keher - Issue of new shares under the DBP

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Nicholas Keher
 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer
 b)  Initial/Amendment notification                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Oxford Nanopore Technologies plc
 b)  LEI                                                          213800IRWQ2Q6M2CDW55
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument   Ordinary shares of £0.0001 each

     Identification code

                                                                  GB00BP6S8Z30
 b)  Nature of the transaction                                    Vesting of awards made under the Deferred Bonus Plan 2021
 c)  Price(s) and volumes(s)

Price(s)  Volume(s)
                                                                  Nil       48,920
 d)  Aggregated information

     - Aggregated volume                                          48,920

     - Aggregated price                                           Nil
 e)  Date of the transaction                                      14 April 2026
 f)  Place of the transaction                                     London Stock Exchange (XLON)

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

48,920

Nil

e)

Date of the transaction

14 April 2026

f)

Place of the transaction

London Stock Exchange (XLON)

 

Nicholas Keher - Sale of new shares under the DBP

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Nicholas Keher
 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer
 b)  Initial/Amendment notification                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Oxford Nanopore Technologies plc
 b)  LEI                                                          213800IRWQ2Q6M2CDW55
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument   Ordinary shares of £0.0001 each

     Identification code

                                                                  GB00BP6S8Z30
 b)  Nature of the transaction                                    Sale
 c)  Price(s) and volumes(s)

Price(s)  Volume(s)
                                                                  £1.0848   22,993
 d)  Aggregated information

     - Aggregated volume                                          22,993

     - Aggregated price                                           £24,942.94
 e)  Date of the transaction                                      14 April 2026
 f)  Place of the transaction                                     London Stock Exchange (XLON)

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

22,993

£24,942.94

e)

Date of the transaction

14 April 2026

f)

Place of the transaction

London Stock Exchange (XLON)

 ENDS 

Enquiries:

Investors

ir@nanoporetech.com (mailto:ir@nanoporetech.com)

Media

media@nanoporetech.com (mailto:media@nanoporetech.com)

OxfordNanoporeTechnologies@teneo.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHGPUPUCUPQGQA



            Copyright 2019 Regulatory News Service, all rights reserved